1-7 of 7
Sumeer Dhar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1884: Optical coherence tomography for label-free real 3D imaging of ex-vivo tumor cultures

Maria Mitsi, Riccardo Urbane, Benjamin Simon, Yasushi Kuromi, Ryo Hasebe, Sumeer Dhar
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1884.
https://doi.org/10.1158/1538-7445.AM2022-1884
Published: 15 June 2022
View articletitled, Abstract 1884: Optical coherence tomography for label-free real 3D imaging of ex-vivo tumor cultures
Journal Articles

Abstract 3722: Novel Optical Coherence Tomography (OCT) technology for no-invasive 3D ex vivo drug activity profiling

Sumeer Dhar, Akihiro Ueda, Takemitsu Muira, Yasushi Kuromi, Yuki Mori, Hiroki Fujimoto
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3722.
https://doi.org/10.1158/1538-7445.AM2019-3722
Published: 01 July 2019
View articletitled, Abstract 3722: Novel Optical Coherence Tomography (OCT) technology for no-invasive 3D ex vivo drug activity profiling
Journal Articles

Abstract 5781: Establishment of a 3D ex-vivo assay as a preclinical drug testing platform for personalized cancer therapy

Sumeer Dhar, Francesca Chiovaro, Tamara Tanos, Tomas Hejhal, Seife Heilemariam, Jens Kelm, Anja Irmisch, Mitchell Levesque
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5781.
https://doi.org/10.1158/1538-7445.AM2017-5781
Published: 01 July 2017
View articletitled, Abstract 5781: Establishment of a 3D ex-vivo assay as a preclinical drug testing platform for personalized cancer therapy
Journal Articles

Abstract 5780: 3D ex-vivo assay platform using primary lung cancer cells in malignant pleural effusions as predictor for clinical outcome of personalized chemotherapy

Cheng-guang Wu, Francesca Chiovaro, Tamara Tanos, Alex Soltermann, Sumeer Dhar
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5780.
https://doi.org/10.1158/1538-7445.AM2017-5780
Published: 01 July 2017
View articletitled, Abstract 5780: 3D ex-vivo assay platform using primary lung cancer cells in malignant pleural effusions as predictor for clinical outcome of personalized chemotherapy
Journal Articles

Abstract 358: In vitro assessment of tumor relapse in a 3D tumor microtissue model

Sumeer Dhar
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 358.
https://doi.org/10.1158/1538-7445.AM2016-358
Published: 15 July 2016
View articletitled, Abstract 358: In vitro assessment of tumor relapse in a 3D tumor microtissue model
Journal Articles

Resistance marker analysis in several human cancer cell lines with acquired resistance against different cytostatics using SELDI mass spectrometry.

Lukas Orre, Sumeer Dhar, Rolf Lewensohn, Rolf Larsson, Janne Lehtiö
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 822.
Published: 01 April 2004
View articletitled, Resistance marker analysis in several human cancer cell lines with acquired resistance against different cytostatics using SELDI mass spectrometry.
Journal Articles

CHS 828, a Novel Pyridyl Cyanoguanidine with Potent Antitumor Activity in Vitro and in Vivo

Pernille-Julia Vig Hjarnaa, Elin Jonsson, Scilla Latini, Sumeer Dhar, Rolf Larsson, Erik Bramm, Torsten Skov, Lise Binderup
Journal: Cancer Research
Cancer Res (1999) 59 (22): 5751–5757.
Published: 01 November 1999
View articletitled, CHS 828, a Novel Pyridyl Cyanoguanidine with Potent Antitumor Activity in Vitro and in Vivo
Open the PDF for CHS 828, a Novel Pyridyl Cyanoguanidine with Potent Antitumor Activity in Vitro and in Vivo in another window